Dosing information

DATROWAY dosing schedule

DATROWAY is given through an intravenous (IV) infusion that you’ll receive once every 3 weeks at your treatment center or doctor’s office.

3 weeks between doses

Your month might look something like this while on DATROWAY:

Patients receive DATROWAY® on a 3-week cycle
Patients receive DATROWAY® on a 3-week cycle

What to expect on DATROWAY treatment days

Bottle of medicine icon

BEFORE INFUSION

You will be given medicines to help prevent nausea, vomiting, and infusion-related reactions.

IV infusion icon

YOUR FIRST INFUSION

It will take 90 minutes to complete your first IV infusion. Once the infusion is finished, your care team will monitor you for at least 1 hour to see if you have any infusion-related reactions.

Stop watch icon

FUTURE INFUSIONS

If you did not have any side effects after your first infusion, your infusions could last 30 minutes each. Just like your first infusion, after your second infusion you will be monitored by your care team for 1 hour to see if you have any infusion-related reactions. If you did not have any reactions after your second infusion, you will be monitored for at least 30 minutes after each following infusion.

Let your care team know if you are experiencing any side effects.

Key reminders for your DATROWAY treatment days: 

Side effects icon Side effects icon

There are measures you can take at home to help care for certain side effects such as mouth sores or eye problems. See the Managing Side Effects page for more details

Smartphone icon Smartphone icon

Stay entertained: Bring a phone, tablet, or loved one to keep you company

Ice water icon Ice water icon

Holding ice chips or ice water in your mouth throughout the infusion may help with mouth sores

Frequently asked questions

Q: What if I miss an appointment or have to reschedule?

If you miss a planned dose of DATROWAY, call your care team right away to schedule an appointment. Do not wait until the next planned treatment cycle.

Microscope icon

DATROWAY identifies and targets cancer cells